[go: up one dir, main page]

Chesneau et al., 2021 - Google Patents

New method for the expansion of highly purified human regulatory granzyme B-expressing B cells

Chesneau et al., 2021

Document ID
8422012572684494383
Author
Chesneau M
Le Mai H
Brouard S
Publication year
Publication venue
Regulatory B Cells: Methods and Protocols

External Links

Snippet

Abstract Granzyme B (GZMB)-expressing B cells inhibit CD4+ T-lymphocyte proliferation in a contact-and GZMB-dependent manner, through degradation of TCR zeta or induction of T- cell apoptosis. This regulatory B-cell population is present in human healthy individuals and …
Continue reading at link.springer.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material Not used, see subgroups
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C12N5/0087—Purging against subsets of blood cells, e.g. purging alloreactive T cells

Similar Documents

Publication Publication Date Title
Collison et al. In vitro Treg suppression assays
Hutchinson et al. Human regulatory macrophages
Campbell et al. Rapid detection, enrichment and propagation of specific T cell subsets based on cytokine secretion
de Masson et al. Purification and immunophenotypic characterization of human B cells with regulatory functions
CN103436493A (en) Culture method of rapamycin induced regulatory gamma delta T cells
Weiss et al. A comparative study of two separation methods to isolate monocytes
Hou et al. Measuring CTLA-4-dependent suppressive function in regulatory T cells
Chesneau et al. New method for the expansion of highly purified human regulatory granzyme B-expressing B cells
Alculumbre et al. Purification of human dendritic cell subsets from peripheral blood
Mujtahedi et al. Bone marrow derived long-lived plasma cell phenotypes are heterogeneous and can change in culture
Zimmerman et al. Redirecting human conventional and regulatory T cells using chimeric antigen receptors
Kos et al. Flow cytometry-based isolation of tumor-associated regulatory T cells and assessment of their suppressive potential
Karlsson et al. Ex vivo generation of regulatory T cells: characterization and therapeutic evaluation in a model of chronic colitis
Baumjohann et al. Tracking early T follicular helper cell differentiation in vivo
Jonuleit et al. Regulatory T-Cells in Antitumor Therapy Isolation and Functional Testing of CD4+ CD25+ Regulatory T-Cells
Bentebibel et al. Analysis of human blood memory T follicular helper subsets
Mohib et al. Characterization and activity of TIM-1 and IL-10-reporter expressing regulatory B cells
Baecher‐Allan et al. The purification and functional analysis of human CD4+ CD25high regulatory T cells
Omer et al. Characterizing innate lymphoid cell phenotype and function in human inflammatory bowel disease
van der Haar Àvila et al. Evaluating antibody-dependent cell-mediated cytotoxicity by flow cytometry
McMurchy et al. In vitro generation of human T regulatory cells: generation, culture, and analysis of FOXP3-transduced T cells
Li et al. Measurements of Treg cell induction by Candida albicans DNA using flow cytometry
Popescu et al. Phenotypic and functional characterization of cytotoxic T lymphocytes by flow cytometry
Sarhan et al. Assessing canonical and adaptive natural killer cell function in suppression assays in vitro
Trabanelli et al. Immunophenotyping of human innate lymphoid cells